HD Immune

HD Immune is dedicated to developing novel antibody therapies for patients with Huntington's disease. Huntington's Disease (HD) is a rare neurological disorder and a fatal condition with no cure, and to date, no drugs have been developed that can alleviate its symptoms. In response to this unmet medical need, HD Immune aims to develop a monoclonal antibody capable of interfering with the progression of the disease and slowing the further development of clinical symptoms.